SENZAR ASSET MANAGEMENT, LLC Historic Quarter Change: Foreign Stocks, Added

SENZAR ASSET MANAGEMENT, LLC historic quarter change: Foreign Stocks, Added

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 11 quarters from 2013-12-31 to 2016-09-30, SENZAR ASSET MANAGEMENT, LLC opened 1 positions, added to 12, reduced 3 and sold out of 3.

Q3 2016: Stock SNY; Country of operation —; Class SPONSORED ADR; Shares before 1,103,300.
Q4 2015: Stock TEVA; Country of operation —; Class ADR; Shares before 1,214,494.
Q3 2015: Stock TEVA; Country of operation —; Class ADR; Shares before 877,497.
Q2 2015: Stock TEVA; Country of operation —; Class ADR; Shares before 551,197.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1579853), 11 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2013-12-31.

Quarter	Stock	Class	Shares before	Shares after	Share change	Value before	Value after	Value change	Filed
Q3 2016	SNY SANOFI	SPONSORED ADR	1,103,300	1,434,600	+331,300	$46,173,105,000	$54,787,374,000	+$8,614,269,000	2016-11-14
Q4 2015	TEVA TEVA PHARMACEUTICAL INDS LTD	ADR	1,214,494	1,281,189	+66,695	$68,570,331,000	$84,097,246,000	+$15,526,915,000	2016-02-12
Q3 2015	TEVA TEVA PHARMACEUTICAL INDS LTD	ADR	877,497	1,214,494	+336,997	$51,860,000	$68,570,331,000	+$68,518,471,000	2015-11-16
Q2 2015	TEVA TEVA PHARMACEUTICAL INDS LTD	ADR	551,197	877,497	+326,300	$34,340,000	$51,860,000	+$17,520,000	2015-08-14
Q1 2015	TEVA TEVA PHARMACEUTICAL INDS LTD	ADR	230,897	551,197	+320,300	$13,279,000	$34,340,000	+$21,061,000	2015-05-15
Q4 2014	SNY SANOFI	SPONSORED ADR	488,100	705,112	+217,012	$27,543,000	$32,160,000	+$4,617,000	2015-02-17
Q3 2014	TEVA TEVA PHARMACEUTICAL INDS LTD	ADR	490,996	568,396	+77,400	$25,739,000	$30,551,000	+$4,812,000	2014-11-14
Q3 2014	SNY SANOFI	SPONSORED ADR	478,600	488,100	+9,500	$25,447,000	$27,543,000	+$2,096,000	2014-11-14
Q2 2014	TEVA TEVA PHARMACEUTICAL INDS LTD	ADR	440,400	490,996	+50,596	$23,271,000	$25,739,000	+$2,468,000	2014-08-14
Q2 2014	SNY SANOFI	SPONSORED ADR	452,600	478,600	+26,000	$23,662,000	$25,447,000	+$1,785,000	2014-08-14
Q1 2014	SNY SANOFI	SPONSORED ADR	117,000	452,600	+335,600	$6,275,000	$23,662,000	+$17,387,000	2014-05-15
Q1 2014	TEVA TEVA PHARMACEUTICAL INDS LTD	ADR	345,300	440,400	+95,100	$13,840,000	$23,271,000	+$9,431,000	2014-05-15

Similar Firms

Firm Name	Country	13F Value	Holdings
Not available yet